The target antigen of ANCA is not always discriminatory; approximately 9% of patients with GPA are MPO-ANCA positive [5], whereas up to 40% of patients with MPA may be PR3-ANCA positive [6]. The gene discussed is PRTN3; the disease is microscopic polyangiitis.